Dr. Lal PathLabs Ltd (NSE:LALPATHLAB)
₹ 3053.05 52.65 (1.75%) Market Cap: 254.35 Bil Enterprise Value: 245.06 Bil PE Ratio: 62.28 PB Ratio: 12.49 GF Score: 100/100

Q1 2023 Dr. Lal PathLabs Ltd Earnings Call Transcript

Jul 28, 2022 / 11:00AM GMT
Release Date Price: ₹2144.5 (-1.18%)
Operator

Ladies and gentlemen, good day, and welcome to the Dr. Lal PathLabs Q1 FY '23 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Siddharth of CDR India. Thank you, and over to you, sir.

Siddharth Rangnekar
Citigate Dewe Rogerson Communications Private Limited - IR Manager

Thank you, (inaudible). Good evening, everyone, and welcome to Dr. Lal PathLabs Quarter 1 FY '23 Earnings Conference Call. Today, we are joined by senior members of the management team, including honorary Brigadier, Dr. Arvind Lal, Executive Chairman; Dr. Om Prakash Manchanda, Managing Director; Mr. Bharath Uppiliappan, CEO; Mr. Ved Prakash Goel, Group CFO; along with Mr. Shankha Banerjee, CEO of Suburban and other Group Companies; Mr. Rajat Kalra, Company Secretary and Head of Investor Relations.

I would like to share that our standard disclaimer here. Some of the statements made on today's call could be forward-looking in nature, and actual results could vary from these forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot